anti-NLRP3-ASC antibody (AC Immune)

N/A

Report date: 2025/01/26 19:19:12

Base Information

Drug Nameanti-NLRP3-ASC antibody (AC Immune)
Drug Alias NameNLRP3 Protein Inhibitor (AC Immune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitorsApoptosis-associated speck-like protein containing a CARD inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3Apoptosis-associated speck-like protein containing a CARD
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAc Immune Sa
China Registration ClassN/A

Develop Information

Active CompaniesAc Immune Sa
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A